US 11147883
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
granted A61KA61K2039/505A61K31/337
Quick answer
US patent 11147883 (Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K31/337, A61K31/704, A61K31/7088